Xiaole Shirley Liu
@XShirleyLiu
Followers
10K
Following
22
Media
18
Statuses
365
Computational biologist specializing in data sciences of transcriptional and epigenetic gene regulation, CRISPR screens, and cancer Immunology
Boston, MA
Joined October 2016
RT @sitcancer: #SITC is pleased to announce the 2025 SITC-NCI Computational Immuno-oncology Webinar Series! This series will focus specific….
0
3
0
Hope to see everyone at the 25th HYSTA annual conference:
2
0
6
Excited to share our recent progress at the Access China Partnering Forum!.
1
1
10
GV20 Therapeutics Presents Promising Phase 1 Monotherapy Data on Novel Checkpoint Inhibitor GV20-0251 at ESMO Congress 2024 (. GV20-0251 shows favorable safety profile and preliminary efficacy signals in monotherapy dose escalation.
3
0
15
#AASF is organizing a short video competition (up to 40 winners, a certificate & $1000). ( A celebration for the winners at the public Asian American Pioneer Award ceremony at Stanford on 7/27, a social opportunity to meet scientists and leaders.
0
3
17
Honored to know two wonderful female oncologists. Congrats to Pat on becoming the AACR president and Lilian on becoming the AACR president elect! Also very happy to share our work in an oral presentation at AACR
1
4
72
Look forward to showing investors our technology platform and our lead program GV20-0251 (the 1st AI-predicted antibody and #AI-designed #antibody in the clinic, against a novel #InnateImmune checkpoint #IGSF8).
0
4
45
#IO360 brings the perfect mix of audiences interested in IO: scientists, clinicians, entrepreneurs, pharma executives, investors, and service providers, etc. Always great to see @PatrickHwuMD and get his advice!.
Excited to be in #NYC for the 10th Annual Immuno-Oncology 360° Summit, where I gave a keynote address on the Future of TIL Therapy this morning! It’s been wonderful seeing so many colleagues and friends! #IO360. #MartinaMolgora (@WUSTL) who will be joining us @MoffittNews in June
0
3
38
RT @Atelfo: New big blog post covering the history of the pharma industry, why drugs cost orders of magnitude more to develop now than in t….
0
126
0
Big Data & AI Precision Medicine Conference in the Bay Area.
2
14
54
0
1
4
This Nature article featuring GV20's STEAD technology platform and the lead program is probably the best to explain why I left DFCI / Harvard to join GV20 full-time.
2
36
182
Tumor RNA-seq is becoming cheaper over time and generates rich insights when analyzed well. RIMA is a computational pipeline with comprehensive features and tutorial to enable effective tumor RNA-seq analysis.
0
51
184
Want to join an AI-based antibody therapeutics company with a 1st-in-class molecule in the clinic and help us solve the antibody code? Please consider GV20!
0
7
34
Congratulations to @TheodorisLab on the recent study, demonstrating the power of AI learning from big data to make meaningful predictions on limited data.
We are excited to share Geneformer, our foundation model pretrained on 30 million single cell transcriptomes to enable predictions in network biology. Manuscript: Model: Pretraining corpus:
0
7
33
Every year, students at @HelloNEIA team up to design, manufacture, market, and sell a product in two months. This year, Pop! Soap team improved and expanded their products, and focused more on their online marketing efforts (. Go Aaron!.
2
2
9
Look forward to the AI in Cancer Immunotherapy session in the August IO Summit in Boston:
0
4
21